Q1 2024 · 13F-HR
Nan Fung Group Holdings Ltdholdings as filed
Filed 2024-05-14 · accession 0001012975-24-000206
$107.9M
Reported value
45
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 452327109 | ILMN | ILLUMINA INC | $16.4M | 15.2% | 119,196 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $12.4M | 11.5% | 368,665 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $10.5M | 9.69% | 263,940 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $5.3M | 4.87% | 436,378 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $5.1M | 4.73% | 1,883,179 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA PLC | $4.9M | 4.56% | 859,892 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $4.6M | 4.26% | 106,680 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $4.4M | 4.05% | 1,324,550 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $4.2M | 3.91% | 74,022 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $4.0M | 3.73% | 89,516 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $3.6M | 3.34% | 23,022 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $2.6M | 2.41% | 219,277 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $2.6M | 2.37% | 118,255 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $2.4M | 2.24% | 96,100 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $2.1M | 1.97% | 49,120 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.1M | 1.90% | 13,600 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $1.9M | 1.76% | 102,984 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $1.7M | 1.55% | 204,939 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $1.6M | 1.51% | 1,166,952 | Common | SOLE |
| 753018100 | RANI | RANI THERAPEUTICS HLDGS INC | $1.5M | 1.42% | 493,584 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $1.5M | 1.41% | 64,200 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $1.5M | 1.41% | 5,682 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $1.4M | 1.31% | 47,936 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $1.0M | 0.95% | 274,488 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $944,582 | 0.88% | 10,815 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $870,581 | 0.81% | 63,315 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $804,379 | 0.75% | 47,150 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $695,492 | 0.64% | 49,082 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $598,000 | 0.55% | 40,000 | Common | SOLE |
| 04746L104 | — | ATHIRA PHARMA INC | $493,200 | 0.46% | 180,000 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $480,602 | 0.45% | 20,987 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $467,743 | 0.43% | 41,950 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $438,750 | 0.41% | 6,750 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $437,175 | 0.41% | 10,875 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $366,689 | 0.34% | 7,450 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $342,234 | 0.32% | 32,470 | Common | SOLE |
| 23306J101 | — | DBV TECHNOLOGIES S A | $277,879 | 0.26% | 370,950 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $235,279 | 0.22% | 7,300 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $230,899 | 0.21% | 50,971 | Common | SOLE |
| N01045207 | AFMDQ | AFFIMED N V | $197,409 | 0.18% | 37,247 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $187,183 | 0.17% | 36,847 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $167,910 | 0.16% | 31,922 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $165,007 | 0.15% | 15,700 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $145,949 | 0.14% | 62,106 | Common | SOLE |
| 36338D108 | GRTX | GALERA THERAPEUTICS INC | $85,851 | 0.08% | 613,223 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.